Annegien Broeks
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.
Journal: Journal of the National Cancer Institute
Published: February 25, 2026
Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.
Journal: Breast (Edinburgh, Scotland)
Published: September 10, 2025
Implementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients' perspectives.
Journal: BMC medical ethics
Published: September 05, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 30, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 05, 2025
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.
Journal: Communications medicine
Published: January 31, 2025
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 23, 2025
Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.
Journal: Cancer discovery
Published: November 14, 2024
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial.
Journal: Nature communications
Published: October 22, 2024
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank.
Journal: Annals of diagnostic pathology
Published: October 12, 2024
Last Updated: 09/26/2026